• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌中与失巢凋亡相关lncRNAs的鉴定、验证及其预后意义和免疫微环境特征分析

Identification and validation of anoikis-related lncRNAs for prognostic significance and immune microenvironment characterization in ovarian cancer.

作者信息

Cao Lixue, Zhang Shaofen, Peng Haojie, Lin Yongqing, Xi Zhihui, Lin Wumei, Guo Jialing, Wu Geyan, Yu Fei, Zhang Hui, Ye Haiyan

机构信息

Medical Research Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.

Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.

出版信息

Aging (Albany NY). 2024 Jan 15;16(2):1463-1483. doi: 10.18632/aging.205439.

DOI:10.18632/aging.205439
PMID:38226979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10866438/
Abstract

Anoikis, a form of apoptotic cell death resulting from inadequate cell-matrix interactions, has been implicated in tumor progression by regulating tumor angiogenesis and metastasis. However, the potential roles of anoikis-related long non-coding RNAs (arlncRNAs) in the tumor microenvironment are not well understood. In this study, five candidate lncRNAs were screened through least absolute shrinkage and selection operator (LASSO), and multivariate Cox regression analysis based on differentially expressed lncRNAs associated with anoikis-related genes (ARGs) from TCGA and GSE40595 datasets. The prognostic accuracy of the risk model was evaluated using Kaplan-Meier survival analysis and receiver operating characteristic (ROC) curves. Furthermore, Kyoto Encyclopedia of Genes and Genomes (KEGG) and gene set enrichment analysis (GSEA) analyses revealed significant differences in immune-related hallmarks and signal transduction pathways between the high-risk and low-risk groups. Additionally, immune infiltrate analysis showed significant differences in the distribution of macrophages M2, follicular T helper cells, plasma cells, and neutrophils between the two risk groups. Lastly, silencing the expression of PRR34_AS1 and SPAG5_AS1 significantly increased anoikis-induced cell death in ovarian cancer cells. In conclusion, our study constructed a risk model that can predict clinicopathological features, tumor microenvironment characteristics, and prognosis of ovarian cancer patients. The immune-related pathways identified in this study may offer new treatment strategies for ovarian cancer.

摘要

失巢凋亡是一种由于细胞与基质相互作用不足而导致的凋亡性细胞死亡形式,通过调节肿瘤血管生成和转移参与肿瘤进展。然而,与失巢凋亡相关的长链非编码RNA(arlncRNAs)在肿瘤微环境中的潜在作用尚未完全明确。在本研究中,通过最小绝对收缩和选择算子(LASSO)以及基于来自TCGA和GSE40595数据集的与失巢凋亡相关基因(ARGs)相关的差异表达lncRNAs进行多变量Cox回归分析,筛选出5个候选lncRNAs。使用Kaplan-Meier生存分析和受试者工作特征(ROC)曲线评估风险模型的预后准确性。此外,京都基因与基因组百科全书(KEGG)和基因集富集分析(GSEA)分析显示,高风险组和低风险组在免疫相关特征和信号转导途径方面存在显著差异。此外,免疫浸润分析表明,两个风险组在M2巨噬细胞、滤泡辅助性T细胞、浆细胞和中性粒细胞的分布上存在显著差异。最后,沉默PRR34_AS1和SPAG5_AS1的表达显著增加了卵巢癌细胞中失巢凋亡诱导的细胞死亡。总之,我们的研究构建了一个可以预测卵巢癌患者临床病理特征、肿瘤微环境特征和预后的风险模型。本研究中确定的免疫相关途径可能为卵巢癌提供新的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4178/10866438/cea2213e388a/aging-16-205439-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4178/10866438/26f072c197ff/aging-16-205439-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4178/10866438/d9cac8656e18/aging-16-205439-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4178/10866438/e9ada8653c4c/aging-16-205439-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4178/10866438/44940ce43126/aging-16-205439-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4178/10866438/ee98b231d72b/aging-16-205439-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4178/10866438/eac430db984f/aging-16-205439-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4178/10866438/bab580b15f2d/aging-16-205439-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4178/10866438/cea2213e388a/aging-16-205439-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4178/10866438/26f072c197ff/aging-16-205439-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4178/10866438/d9cac8656e18/aging-16-205439-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4178/10866438/e9ada8653c4c/aging-16-205439-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4178/10866438/44940ce43126/aging-16-205439-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4178/10866438/ee98b231d72b/aging-16-205439-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4178/10866438/eac430db984f/aging-16-205439-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4178/10866438/bab580b15f2d/aging-16-205439-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4178/10866438/cea2213e388a/aging-16-205439-g008.jpg

相似文献

1
Identification and validation of anoikis-related lncRNAs for prognostic significance and immune microenvironment characterization in ovarian cancer.卵巢癌中与失巢凋亡相关lncRNAs的鉴定、验证及其预后意义和免疫微环境特征分析
Aging (Albany NY). 2024 Jan 15;16(2):1463-1483. doi: 10.18632/aging.205439.
2
Anoikis-related lncRNA signature predicts prognosis and is associated with immune infiltration in hepatocellular carcinoma.无锚定相关长非编码 RNA 特征可预测肝细胞癌的预后,并与免疫浸润相关。
Anticancer Drugs. 2024 Jun 1;35(5):466-480. doi: 10.1097/CAD.0000000000001589. Epub 2024 Mar 11.
3
Clinical value of molecular subtypes identification based on anoikis-related lncRNAs in castration-resistant prostate cancer.基于失巢凋亡相关长链非编码RNA的分子亚型鉴定在去势抵抗性前列腺癌中的临床价值
Cell Signal. 2024 May;117:111104. doi: 10.1016/j.cellsig.2024.111104. Epub 2024 Feb 17.
4
A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.基于免疫相关长非编码 RNA 的上皮性卵巢癌预后模型。
J Ovarian Res. 2022 Jan 15;15(1):8. doi: 10.1186/s13048-021-00930-w.
5
Construction of stomach adenocarcinoma prognostic signature based on anoikis-related lncRNAs and clinical significance.基于失巢凋亡相关 lncRNAs 的胃癌预后signature 的构建及其临床意义。
Libyan J Med. 2023 Dec;18(1):2220153. doi: 10.1080/19932820.2023.2220153.
6
Predicting the prognosis, immune response, and immunotherapy in head and neck squamous cell carcinoma using a novel risk model based on anoikis-related lncRNAs.基于失巢凋亡相关长非编码 RNA 的新型风险模型预测头颈部鳞状细胞癌的预后、免疫反应和免疫治疗。
Eur J Med Res. 2023 Nov 28;28(1):548. doi: 10.1186/s40001-023-01521-9.
7
Identification of Novel Anoikis-Related Gene Signatures to Predict the Prognosis, Immune Microenvironment, and Drug Sensitivity of Breast Cancer Patients.鉴定新型失巢凋亡相关基因特征,预测乳腺癌患者的预后、免疫微环境和药物敏感性。
Cancer Control. 2024 Jan-Dec;31:10732748241288118. doi: 10.1177/10732748241288118.
8
Molecular Characterization of Cuproptosis-related lncRNAs: Defining Molecular Subtypes and a Prognostic Signature of Ovarian Cancer.铜死亡相关长链非编码RNA的分子特征:确定卵巢癌的分子亚型和预后特征
Biol Trace Elem Res. 2024 Apr;202(4):1428-1445. doi: 10.1007/s12011-023-03780-3. Epub 2023 Aug 2.
9
Anoikis-related genes in breast cancer patients: reliable biomarker of prognosis.乳腺癌患者的 anoikis 相关基因:可靠的预后生物标志物。
BMC Cancer. 2024 Sep 19;24(1):1163. doi: 10.1186/s12885-024-12830-5.
10
Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma.鉴定和验证与透明细胞肾细胞癌预后相关的新型凋亡相关基因特征。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11661-11678. doi: 10.1007/s00432-023-05012-6. Epub 2023 Jul 5.

引用本文的文献

1
Identification of key biomarkers in breast cancer based on bioinformatics analysis and experimental verification.基于生物信息学分析和实验验证的乳腺癌关键生物标志物鉴定
J Egypt Natl Canc Inst. 2025 Feb 24;37(1):5. doi: 10.1186/s43046-025-00260-8.
2
Develop a Novel Signature to Predict the Survival and Affect the Immune Microenvironment of Osteosarcoma Patients: Anoikis-Related Genes.开发一种新型标志物预测骨肉瘤患者的生存并影响其免疫微环境:与失巢凋亡相关的基因。
J Immunol Res. 2024 Mar 27;2024:6595252. doi: 10.1155/2024/6595252. eCollection 2024.
3
Anoikis-related genes in breast cancer patients: reliable biomarker of prognosis.

本文引用的文献

1
Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments.肿瘤进展和免疫逃逸中的细胞外基质重塑:从机制到治疗。
Mol Cancer. 2023 Mar 11;22(1):48. doi: 10.1186/s12943-023-01744-8.
2
Plasma cell subtypes analyzed using artificial intelligence algorithm for predicting biochemical recurrence, immune escape potential, and immunotherapy response of prostate cancer.利用人工智能算法分析浆细胞亚型,预测前列腺癌的生化复发、免疫逃逸潜能和免疫治疗反应。
Front Immunol. 2022 Dec 8;13:946209. doi: 10.3389/fimmu.2022.946209. eCollection 2022.
3
Comprehensive analysis of anoikis-related long non-coding RNA immune infiltration in patients with bladder cancer and immunotherapy.
乳腺癌患者的 anoikis 相关基因:可靠的预后生物标志物。
BMC Cancer. 2024 Sep 19;24(1):1163. doi: 10.1186/s12885-024-12830-5.
膀胱癌患者 anoikis 相关长非编码 RNA 免疫浸润的综合分析与免疫治疗。
Front Immunol. 2022 Nov 25;13:1055304. doi: 10.3389/fimmu.2022.1055304. eCollection 2022.
4
Anoikis-Associated Lung Cancer Metastasis: Mechanisms and Therapies.失巢凋亡相关的肺癌转移:机制与治疗
Cancers (Basel). 2022 Sep 30;14(19):4791. doi: 10.3390/cancers14194791.
5
CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells.环状 RNA CEMIP 通过增强前列腺癌细胞的保护性自噬促进失巢凋亡抵抗。
J Exp Clin Cancer Res. 2022 Jun 2;41(1):188. doi: 10.1186/s13046-022-02381-7.
6
Potential clinical utility of liquid biopsies in ovarian cancer.液体活检在卵巢癌中的潜在临床应用。
Mol Cancer. 2022 May 11;21(1):114. doi: 10.1186/s12943-022-01588-8.
7
Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis.多组学方法在早期卵巢癌诊断中的生物标志物发现。
EBioMedicine. 2022 May;79:104001. doi: 10.1016/j.ebiom.2022.104001. Epub 2022 Apr 16.
8
Human B Cells Mediate Innate Anti-Cancer Cytotoxicity Through Concurrent Engagement of Multiple TNF Superfamily Ligands.人类 B 细胞通过同时结合多种 TNF 超家族配体来介导先天抗肿瘤细胞毒性。
Front Immunol. 2022 Mar 22;13:837842. doi: 10.3389/fimmu.2022.837842. eCollection 2022.
9
Emerging perspectives on growth factor metabolic relationships in the ovarian cancer ascites environment.卵巢癌腹水微环境中生长因子代谢关系的新观点。
Semin Cancer Biol. 2022 Nov;86(Pt 2):709-719. doi: 10.1016/j.semcancer.2022.03.004. Epub 2022 Mar 5.
10
The crosstalk between reactive oxygen species and noncoding RNAs: from cancer code to drug role.活性氧物种与非编码 RNA 之间的串扰:从癌症密码到药物作用。
Mol Cancer. 2022 Jan 26;21(1):30. doi: 10.1186/s12943-021-01488-3.